查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1798029

2032年卵子冷凍和胚胎庫市場預測：按服務類型、儲存方式、年齡層、技術、應用、最終用戶和地區進行的全球分析

Egg Freezing and Embryo Banking Market Forecasts to 2032 - Global Analysis By Service Type, Preservation Method, Age Group, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球卵子冷凍和胚胎銀行市場規模預計在 2025 年達到 53.7 億美元，到 2032 年將達到 117 億美元，預測期內複合年成長率為 11.8%。

女性成熟的卵子被取出、冷凍並儲存，以提高其日後受孕的幾率，這項生育力保存技術被稱為卵子冷凍（也稱為卵子冷凍保存）。卵巢刺激、卵子取出以及透過玻璃化冷凍快速冷凍，用於保存細胞的完整性。在實驗室環境下，透過卵子和精子受精，通常透過體外受精 (IVF) 來創造、冷凍和儲存胚胎的過程被稱為胚胎銀行。這些技術為個人和夫婦提供了生育靈活性，有助於在老齡化或接受治療之前保持生育能力，並可用於醫療、社會或個人目的。

根據歐洲人類生殖與胚胎學會的數據，全球每年實施的輔助生殖技術（ART）手術超過300萬例。因此，隨著ART手術的普及，短期供應的需求也隨之成長。

不孕症問題日益嚴重，醫學原因日益突出

由於壓力、推遲生育計畫以及生活方式的改變，不孕症率不斷上升，導致對生育力保存服務的需求日益成長。許多人選擇冷凍卵子，以防止因老齡化成長而導致的生育力下降。患有癌症、子宮內膜異位症和遺傳性疾病等疾病的患者也被鼓勵在接受可能影響生育力的治療之前儲存卵子或胚胎。生殖技術的進步正在提高這些程序的可及性和有效性。這些因素的綜合作用將顯著加速市場擴大和普及的速度。

高成本和負擔能力問題

手術涉及昂貴的治療、藥物和儲存費用。許多人，尤其是在中低收入地區，無法負擔這些服務。有限的保險保障進一步加重了經濟負擔。因此，潛在用戶會延後或避免生育力保存方案。這限制了市場成長，並限制了獲得高級生殖保健服務的機會。

意識和接受度不斷提高

當人們充分了解生殖保健知識時，他們更有可能考慮這種可能性。社會認可度可以減少恥辱感，使更多人更容易獲得生育治療。媒體的關注和醫療保健提供者的宣傳活動進一步凸顯了生育治療的益處。提供此類福利的雇主接受度的提高也促進了人們的接受度。總體而言，認知度和接受度推動了市場成長和基本客群的擴大。

基礎設施和訪問限制

許多地區缺乏現代化的生育診所和專業的儲存設施。缺乏合格的醫務人員降低了服務品質和範圍。冷凍保存設備和實驗室的高昂推出成本限制了其擴張。患者難以前往偏遠地區的醫療機構。這些障礙限制了市場滲透，並阻礙了其廣泛應用。

COVID-19的影響

新冠疫情嚴重擾亂了卵子冷凍和胚胎庫市場，診所關閉和旅行限制導致生育治療延誤。擇期手術延後，服務需求暫時減少。供應鏈中斷影響了醫療設備和用品的供應。然而，隨著生殖健康意識的增強，加上對懷孕延遲的擔憂，疫情過後人們對生育治療的興趣有所提升。遠端醫療諮詢的實施有助於維持與病患的關係，診所也調整並加強了安全通訊協定，以有效率地恢復業務。

預測期內玻璃化固化細分市場預計將佔最大佔有率

預計玻璃化冷凍技術將在預測期內佔據最大的市場佔有率，因為它能夠快速冷凍，防止冰晶形成，從而提高細胞活力。這項先進技術提高了卵子和胚胎解凍後的存活率，從而增加了成功受精和懷孕的幾率。其高效性和可靠性使其成為生育診所和患者的首選方法。其較短的處理時間也降低了營運成本並改善了臨床工作流程。玻璃化冷凍技術的認知度和應用日益成長，正在推動全球市場的成長。

預計冷凍庫部分將在預測期內實現最高的複合年成長率

由於先進的儲存設施，生殖材料能夠長期保存，預計冷凍庫細分市場將在預測期內實現最高成長率。冷凍庫提供安全、溫控的環境，能夠長期維持卵子和胚胎的活力和品質。冷凍庫也透過與生殖診所合作，提供便利的取卵服務，擴大了服務的可近性。冷凍庫冷凍保存方法的技術進步正在提高解凍後的存活率，並提高輔助生殖治療的成功率。

佔比最高的地區

預計北美地區將在預測期內佔據最大的市場佔有率，這得益於人們對不孕症的高度認知、雇主資助的社會福利以及發達的醫療保健基礎設施。為了職業或教育而推遲生育的普遍趨勢，以及大公司提供的卵子冷凍保險，也在顯著加速冷凍技術的普及。技術優勢包括玻璃化冷凍作為標準的冷凍保存方法、延時成像、人工智慧輔助胚胎選擇以及整合到大型診所的胚胎著床前基因檢測系統。雇主和保險公司在資助這些服務、降低成本障礙和擴大不孕症治療的可近性方面發揮關鍵作用。

複合年成長率最高的地區

由於不孕症盛行率上升、可支配收入增加以及中國、印度、日本和韓國等國家都市區女性勞動力規模不斷擴大，預計亞太地區在預測期內的複合年成長率最高。東京的生育治療津貼和澳洲擴大試管嬰兒返利計畫等國家舉措正在提高生育治療的可及性和消費者意識。技術創新趨勢包括超快速玻璃化冷凍、基於區塊鏈的安全冷凍保存、跨境胚胎庫的可擴展性，以及針對區域基因篩檢和胚胎評估的人工智慧診斷工具。隨著區域診所提供經濟高效且先進的生育治療服務，醫療旅遊業也加速成長。

提供免費客製化

訂閱此報告的客戶將獲得以下免費自訂選項之一：

  • 公司簡介
    • 對最多三家其他市場參與企業進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 透過產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 二手研究資料
    • 先決條件

第3章市場走勢分析

  • 介紹
  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球卵子冷凍及胚胎庫市場（依服務類型）

  • 介紹
  • 冷凍卵子
  • 胚胎庫
  • 其他

6. 全球卵子冷凍及胚胎庫市場（依儲存方式）

  • 介紹
  • 慢速冷凍
  • 玻璃化冷凍

7. 全球卵子冷凍及胚胎庫市場（依年齡層）

  • 介紹
  • 30歲以下
  • 30-39歲
  • 40歲或以上
  • 其他年齡段

8. 全球卵子冷凍及胚胎庫市場（依技術）

  • 介紹
  • 體外受精（IVF）
  • 卵細胞質內單一精蟲顯微注射術（ICSI）
  • 其他

9. 全球卵子冷凍及胚胎庫市場（依應用）

  • 介紹
  • 醫學生育力保存
  • 選擇性生育力保存

第10章全球卵子冷凍和胚胎庫市場（按最終用戶）

  • 介紹
  • 不孕不育診所
  • 醫院
  • 冷凍庫
  • 其他

第 11 章。全球卵子冷凍和胚胎庫市場（按地區）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章：企業概況

  • The Cooper Companies
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Vitrolife AB
  • Ferring Pharmaceuticals
  • Kindbody
  • Virtus Health Limited
  • Monash IVF Group
  • Progyny, Inc.
  • Shady Grove Fertility
  • Cryos International
  • California Cryobank
  • IVIRMA Global
  • FUJIFILM Irvine Scientific
  • Hamilton Thorne Ltd.
Product Code: SMRC30399

According to Stratistics MRC, the Global Egg Freezing and Embryo Banking Market is accounted for $5.37 billion in 2025 and is expected to reach $11.7 billion by 2032 growing at a CAGR of 11.8% during the forecast period. A woman's mature eggs are removed, frozen, and saved for later use in a fertility preservation procedure called egg freezing, also known as oocyte cryopreservation, which increases the likelihood of getting pregnant later in life. In order to preserve cell integrity, the procedure entails ovarian stimulation, egg removal, and quick freezing via vitrification. The process of creating, freezing, and storing embryos created by fertilizing eggs with sperm in a lab environment typically through in vitro fertilization (IVF) is known as embryo banking. These techniques, which give people or couples more reproductive flexibility and help, maintain fertility before ageing or medical treatments, are utilized for medical, social, or private reasons.

According to European Society of Human Reproduction and Embryology, more than 3 million ART cycles are performed annually across the world. Therefore, as the adoption of ART procedures expands so does the need for short term shortage.

Market Dynamics:

Driver:

Rising fertility concerns & medical reasons

The need for fertility preservation services has increased as a result of rising infertility rates brought on by stress, delayed family planning, and changes in lifestyle. As a preventative measure to preserve reproductive potential prior to age-related decline, many people choose to freeze their eggs. Before undertaking therapies that may affect fertility, patients with medical problems including cancer, endometriosis, or genetic diseases are also encouraged to preserve their eggs or embryos. Reproductive technology advancements have improved the accessibility and efficacy of these operations. When combined, these elements greatly accelerate the market's expansion and pace of adoption.

Restraint:

High costs & affordability issues

The procedures involve expensive medical treatments, medications, and storage fees. Many individuals, especially in low- and middle-income regions, cannot afford these services. Limited insurance coverage further increases the financial burden. As a result, potential users delay or avoid opting for fertility preservation. This restricts market growth and limits access to advanced reproductive options.

Opportunity:

Growing awareness & acceptance

People are more inclined to think about these possibilities sooner when they are well informed about reproductive health. As stigma is lessened by social acceptability, more people are becoming receptive to fertility preservation. The advantages are further emphasized by media attention and healthcare provider campaigns. Adoption is also aided by growing acceptance among employers who provide these perks. In general, market growth and client base expansion are being facilitated by awareness and acceptance.

Threat:

Infrastructure & access limitations

Modern fertility clinics and specialised storage facilities are scarce in many areas. The quality and scope of services are diminished by the scarcity of qualified medical personnel. Expansion is limited by the high startup costs for cryopreservation equipment and labs. Patients have trouble getting to healthcare facilities in isolated places. These obstacles restrict market penetration and impede adoption.

Covid-19 Impact:

The Covid 19 pandemic significantly disrupted the Egg Freezing and Embryo Banking Market, causing delays in fertility treatments due to clinic closures and travel restrictions. Elective procedures were postponed, leading to a temporary decline in service demand. Supply chain interruptions affected the availability of medical equipment and consumables. However, increased awareness of reproductive health, coupled with concerns over delayed pregnancies, boosted interest in fertility preservation post pandemic. Telemedicine adoption and digital consultations helped sustain patient engagement, while clinics adapted with enhanced safety protocols to resume operations efficiently.

The vitrification segment is expected to be the largest during the forecast period

The vitrification segment is expected to account for the largest market share during the forecast period by offering a rapid-freezing process that prevents ice crystal formation, ensuring higher cell survival rates. This advanced technique improves post-thaw viability of eggs and embryos, increasing the chances of successful fertilization and pregnancy. Its efficiency and reliability make it a preferred method among fertility clinics and patients. The shorter processing time also reduces operational costs and enhances clinical workflow. Growing awareness and adoption of vitrification technology are driving market growth globally.

The cryobanks segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cryobanks segment is predicted to witness the highest growth rate due to advanced storage facilities that ensure the long-term preservation of reproductive materials. They offer secure and temperature-controlled environments, maintaining the viability and quality of eggs and embryos for extended periods. Cryobanks also expand accessibility by partnering with fertility clinics and offering convenient retrieval services. Technological advancements in cryopreservation methods within cryobanks improve survival rates after thawing, enhancing success rates of fertility treatments.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share is propelled by high fertility awareness, supportive employer sponsored benefits, and well developed healthcare infrastructure. The widespread trend of postponing parenthood for careers or education, combined with offers of egg freezing insurance by large corporations, also significantly accelerates adoption. Technological advantages include vitrification as the standard cryopreservation method, time-lapse imaging, AI driven embryo selection, and preimplantation genetic testing systems embedded in leading clinics. Employers and insurers play a key role by funding these services, reducing cost barriers, and widening access to fertility preservation.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR by rising infertility, increasing disposable incomes, and expanding urban female workforce participation in countries such as China, India, Japan, and South Korea. National government initiatives such as fertility subsidies in Tokyo and expanded IVF rebate programs in Australia-boost accessibility and consumer awareness. Innovation trends include ultra rapid vitrification, blockchain secured cry storage, scalability of embryo banks across borders, and AI based diagnostic tools tailored for local genetic screening and embryo assessment. Medical tourism also accelerates growth as regional clinics provide cost-effective, advanced fertility preservation services.

Key players in the market

Some of the key players in Egg Freezing and Embryo Banking Market include The Cooper Companies, Merck KGaA, Thermo Fisher Scientific Inc., Vitrolife AB, Ferring Pharmaceuticals, Kindbody, Virtus Health Limited, Monash IVF Group, Progyny, Inc., Shady Grove Fertility, Cryos International, California Cryobank, IVIRMA Global, FUJIFILM Irvine Scientific and Hamilton Thorne Ltd.

Key Developments:

In February 2025, Thermo Fisher Scientific launched the CorEvitas Systemic Lupus Erythematosus (SLE) Registry, a comprehensive real world clinical data platform. It aims to collect, analyze, and share longitudinal patient data to advance understanding, treatment development, and management strategies for autoimmune diseases.

In May 2024, Vitrolife AB acquired eFertility to integrate its eWitness tracking and eBase EMR systems, enabling secure, efficient, and standardized egg freezing and embryo banking workflows. This move strengthens Vitrolife's end to end IVF platform and advances its digital clinic management capabilities.

In May 2023, Thermo Fisher Scientific partnered with Pfizer to broaden access to lung and breast cancer testing, aiming to enhance early detection and personalized treatment. The collaboration focused on advanced diagnostic solutions, with no link to fertility preservation services.

Service Types Covered:

  • Egg Freezing
  • Embryo Banking
  • Other Service Types

Preservation Methods Covered:

  • Slow Freezing
  • Vitrification

Age Groups Covered:

  • <30 Years
  • 30-39 Years
  • >=40 Years
  • Other Age Groups

Technologies Covered:

  • In Vitro Fertilization (IVF)
  • Intracytoplasmic Sperm Injection (ICSI)
  • Other Technologies

Applications Covered:

  • Medical Fertility Preservation
  • Elective Fertility Preservation

End Users Covered:

  • Fertility Clinics
  • Hospitals
  • Cryobanks
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Egg Freezing and Embryo Banking Market, By Service Type

  • 5.1 Introduction
  • 5.2 Egg Freezing
  • 5.3 Embryo Banking
  • 5.4 Other Service Types

6 Global Egg Freezing and Embryo Banking Market, By Preservation Method

  • 6.1 Introduction
  • 6.2 Slow Freezing
  • 6.3 Vitrification

7 Global Egg Freezing and Embryo Banking Market, By Age Group

  • 7.1 Introduction
  • 7.2 <30 Years
  • 7.3 30-39 Years
  • 7.4 >=40 Years
  • 7.5 Other Age Groups

8 Global Egg Freezing and Embryo Banking Market, By Technology

  • 8.1 Introduction
  • 8.2 In Vitro Fertilization (IVF)
  • 8.3 Intracytoplasmic Sperm Injection (ICSI)
  • 8.4 Other Technologies

9 Global Egg Freezing and Embryo Banking Market, By Application

  • 9.1 Introduction
  • 9.2 Medical Fertility Preservation
  • 9.3 Elective Fertility Preservation

10 Global Egg Freezing and Embryo Banking Market, By End User

  • 10.1 Introduction
  • 10.2 Fertility Clinics
  • 10.3 Hospitals
  • 10.4 Cryobanks
  • 10.5 Other End Users

11 Global Egg Freezing and Embryo Banking Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 The Cooper Companies
  • 13.2 Merck KGaA
  • 13.3 Thermo Fisher Scientific Inc.
  • 13.4 Vitrolife AB
  • 13.5 Ferring Pharmaceuticals
  • 13.6 Kindbody
  • 13.7 Virtus Health Limited
  • 13.8 Monash IVF Group
  • 13.9 Progyny, Inc.
  • 13.10 Shady Grove Fertility
  • 13.11 Cryos International
  • 13.12 California Cryobank
  • 13.13 IVIRMA Global
  • 13.14 FUJIFILM Irvine Scientific
  • 13.15 Hamilton Thorne Ltd.

List of Tables

  • Table 1 Global Egg Freezing and Embryo Banking Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Egg Freezing and Embryo Banking Market Outlook, By Service Type (2024-2032) ($MN)
  • Table 3 Global Egg Freezing and Embryo Banking Market Outlook, By Egg Freezing (2024-2032) ($MN)
  • Table 4 Global Egg Freezing and Embryo Banking Market Outlook, By Embryo Banking (2024-2032) ($MN)
  • Table 5 Global Egg Freezing and Embryo Banking Market Outlook, By Other Service Types (2024-2032) ($MN)
  • Table 6 Global Egg Freezing and Embryo Banking Market Outlook, By Preservation Method (2024-2032) ($MN)
  • Table 7 Global Egg Freezing and Embryo Banking Market Outlook, By Slow Freezing (2024-2032) ($MN)
  • Table 8 Global Egg Freezing and Embryo Banking Market Outlook, By Vitrification (2024-2032) ($MN)
  • Table 9 Global Egg Freezing and Embryo Banking Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 10 Global Egg Freezing and Embryo Banking Market Outlook, By <30 Years (2024-2032) ($MN)
  • Table 11 Global Egg Freezing and Embryo Banking Market Outlook, By 30-39 Years (2024-2032) ($MN)
  • Table 12 Global Egg Freezing and Embryo Banking Market Outlook, By >=40 Years (2024-2032) ($MN)
  • Table 13 Global Egg Freezing and Embryo Banking Market Outlook, By Other Age Groups (2024-2032) ($MN)
  • Table 14 Global Egg Freezing and Embryo Banking Market Outlook, By Technology (2024-2032) ($MN)
  • Table 15 Global Egg Freezing and Embryo Banking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
  • Table 16 Global Egg Freezing and Embryo Banking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
  • Table 17 Global Egg Freezing and Embryo Banking Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 18 Global Egg Freezing and Embryo Banking Market Outlook, By Application (2024-2032) ($MN)
  • Table 19 Global Egg Freezing and Embryo Banking Market Outlook, By Medical Fertility Preservation (2024-2032) ($MN)
  • Table 20 Global Egg Freezing and Embryo Banking Market Outlook, By Elective Fertility Preservation (2024-2032) ($MN)
  • Table 21 Global Egg Freezing and Embryo Banking Market Outlook, By End User (2024-2032) ($MN)
  • Table 22 Global Egg Freezing and Embryo Banking Market Outlook, By Fertility Clinics (2024-2032) ($MN)
  • Table 23 Global Egg Freezing and Embryo Banking Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 24 Global Egg Freezing and Embryo Banking Market Outlook, By Cryobanks (2024-2032) ($MN)
  • Table 25 Global Egg Freezing and Embryo Banking Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 26 North America Egg Freezing and Embryo Banking Market Outlook, By Country (2024-2032) ($MN)
  • Table 27 North America Egg Freezing and Embryo Banking Market Outlook, By Service Type (2024-2032) ($MN)
  • Table 28 North America Egg Freezing and Embryo Banking Market Outlook, By Egg Freezing (2024-2032) ($MN)
  • Table 29 North America Egg Freezing and Embryo Banking Market Outlook, By Embryo Banking (2024-2032) ($MN)
  • Table 30 North America Egg Freezing and Embryo Banking Market Outlook, By Other Service Types (2024-2032) ($MN)
  • Table 31 North America Egg Freezing and Embryo Banking Market Outlook, By Preservation Method (2024-2032) ($MN)
  • Table 32 North America Egg Freezing and Embryo Banking Market Outlook, By Slow Freezing (2024-2032) ($MN)
  • Table 33 North America Egg Freezing and Embryo Banking Market Outlook, By Vitrification (2024-2032) ($MN)
  • Table 34 North America Egg Freezing and Embryo Banking Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 35 North America Egg Freezing and Embryo Banking Market Outlook, By <30 Years (2024-2032) ($MN)
  • Table 36 North America Egg Freezing and Embryo Banking Market Outlook, By 30-39 Years (2024-2032) ($MN)
  • Table 37 North America Egg Freezing and Embryo Banking Market Outlook, By >=40 Years (2024-2032) ($MN)
  • Table 38 North America Egg Freezing and Embryo Banking Market Outlook, By Other Age Groups (2024-2032) ($MN)
  • Table 39 North America Egg Freezing and Embryo Banking Market Outlook, By Technology (2024-2032) ($MN)
  • Table 40 North America Egg Freezing and Embryo Banking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
  • Table 41 North America Egg Freezing and Embryo Banking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
  • Table 42 North America Egg Freezing and Embryo Banking Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 43 North America Egg Freezing and Embryo Banking Market Outlook, By Application (2024-2032) ($MN)
  • Table 44 North America Egg Freezing and Embryo Banking Market Outlook, By Medical Fertility Preservation (2024-2032) ($MN)
  • Table 45 North America Egg Freezing and Embryo Banking Market Outlook, By Elective Fertility Preservation (2024-2032) ($MN)
  • Table 46 North America Egg Freezing and Embryo Banking Market Outlook, By End User (2024-2032) ($MN)
  • Table 47 North America Egg Freezing and Embryo Banking Market Outlook, By Fertility Clinics (2024-2032) ($MN)
  • Table 48 North America Egg Freezing and Embryo Banking Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 49 North America Egg Freezing and Embryo Banking Market Outlook, By Cryobanks (2024-2032) ($MN)
  • Table 50 North America Egg Freezing and Embryo Banking Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 51 Europe Egg Freezing and Embryo Banking Market Outlook, By Country (2024-2032) ($MN)
  • Table 52 Europe Egg Freezing and Embryo Banking Market Outlook, By Service Type (2024-2032) ($MN)
  • Table 53 Europe Egg Freezing and Embryo Banking Market Outlook, By Egg Freezing (2024-2032) ($MN)
  • Table 54 Europe Egg Freezing and Embryo Banking Market Outlook, By Embryo Banking (2024-2032) ($MN)
  • Table 55 Europe Egg Freezing and Embryo Banking Market Outlook, By Other Service Types (2024-2032) ($MN)
  • Table 56 Europe Egg Freezing and Embryo Banking Market Outlook, By Preservation Method (2024-2032) ($MN)
  • Table 57 Europe Egg Freezing and Embryo Banking Market Outlook, By Slow Freezing (2024-2032) ($MN)
  • Table 58 Europe Egg Freezing and Embryo Banking Market Outlook, By Vitrification (2024-2032) ($MN)
  • Table 59 Europe Egg Freezing and Embryo Banking Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 60 Europe Egg Freezing and Embryo Banking Market Outlook, By <30 Years (2024-2032) ($MN)
  • Table 61 Europe Egg Freezing and Embryo Banking Market Outlook, By 30-39 Years (2024-2032) ($MN)
  • Table 62 Europe Egg Freezing and Embryo Banking Market Outlook, By >=40 Years (2024-2032) ($MN)
  • Table 63 Europe Egg Freezing and Embryo Banking Market Outlook, By Other Age Groups (2024-2032) ($MN)
  • Table 64 Europe Egg Freezing and Embryo Banking Market Outlook, By Technology (2024-2032) ($MN)
  • Table 65 Europe Egg Freezing and Embryo Banking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
  • Table 66 Europe Egg Freezing and Embryo Banking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
  • Table 67 Europe Egg Freezing and Embryo Banking Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 68 Europe Egg Freezing and Embryo Banking Market Outlook, By Application (2024-2032) ($MN)
  • Table 69 Europe Egg Freezing and Embryo Banking Market Outlook, By Medical Fertility Preservation (2024-2032) ($MN)
  • Table 70 Europe Egg Freezing and Embryo Banking Market Outlook, By Elective Fertility Preservation (2024-2032) ($MN)
  • Table 71 Europe Egg Freezing and Embryo Banking Market Outlook, By End User (2024-2032) ($MN)
  • Table 72 Europe Egg Freezing and Embryo Banking Market Outlook, By Fertility Clinics (2024-2032) ($MN)
  • Table 73 Europe Egg Freezing and Embryo Banking Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 74 Europe Egg Freezing and Embryo Banking Market Outlook, By Cryobanks (2024-2032) ($MN)
  • Table 75 Europe Egg Freezing and Embryo Banking Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 76 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Country (2024-2032) ($MN)
  • Table 77 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Service Type (2024-2032) ($MN)
  • Table 78 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Egg Freezing (2024-2032) ($MN)
  • Table 79 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Embryo Banking (2024-2032) ($MN)
  • Table 80 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Other Service Types (2024-2032) ($MN)
  • Table 81 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Preservation Method (2024-2032) ($MN)
  • Table 82 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Slow Freezing (2024-2032) ($MN)
  • Table 83 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Vitrification (2024-2032) ($MN)
  • Table 84 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 85 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By <30 Years (2024-2032) ($MN)
  • Table 86 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By 30-39 Years (2024-2032) ($MN)
  • Table 87 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By >=40 Years (2024-2032) ($MN)
  • Table 88 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Other Age Groups (2024-2032) ($MN)
  • Table 89 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Technology (2024-2032) ($MN)
  • Table 90 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
  • Table 91 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
  • Table 92 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 93 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Application (2024-2032) ($MN)
  • Table 94 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Medical Fertility Preservation (2024-2032) ($MN)
  • Table 95 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Elective Fertility Preservation (2024-2032) ($MN)
  • Table 96 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By End User (2024-2032) ($MN)
  • Table 97 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Fertility Clinics (2024-2032) ($MN)
  • Table 98 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 99 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Cryobanks (2024-2032) ($MN)
  • Table 100 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 101 South America Egg Freezing and Embryo Banking Market Outlook, By Country (2024-2032) ($MN)
  • Table 102 South America Egg Freezing and Embryo Banking Market Outlook, By Service Type (2024-2032) ($MN)
  • Table 103 South America Egg Freezing and Embryo Banking Market Outlook, By Egg Freezing (2024-2032) ($MN)
  • Table 104 South America Egg Freezing and Embryo Banking Market Outlook, By Embryo Banking (2024-2032) ($MN)
  • Table 105 South America Egg Freezing and Embryo Banking Market Outlook, By Other Service Types (2024-2032) ($MN)
  • Table 106 South America Egg Freezing and Embryo Banking Market Outlook, By Preservation Method (2024-2032) ($MN)
  • Table 107 South America Egg Freezing and Embryo Banking Market Outlook, By Slow Freezing (2024-2032) ($MN)
  • Table 108 South America Egg Freezing and Embryo Banking Market Outlook, By Vitrification (2024-2032) ($MN)
  • Table 109 South America Egg Freezing and Embryo Banking Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 110 South America Egg Freezing and Embryo Banking Market Outlook, By <30 Years (2024-2032) ($MN)
  • Table 111 South America Egg Freezing and Embryo Banking Market Outlook, By 30-39 Years (2024-2032) ($MN)
  • Table 112 South America Egg Freezing and Embryo Banking Market Outlook, By >=40 Years (2024-2032) ($MN)
  • Table 113 South America Egg Freezing and Embryo Banking Market Outlook, By Other Age Groups (2024-2032) ($MN)
  • Table 114 South America Egg Freezing and Embryo Banking Market Outlook, By Technology (2024-2032) ($MN)
  • Table 115 South America Egg Freezing and Embryo Banking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
  • Table 116 South America Egg Freezing and Embryo Banking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
  • Table 117 South America Egg Freezing and Embryo Banking Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 118 South America Egg Freezing and Embryo Banking Market Outlook, By Application (2024-2032) ($MN)
  • Table 119 South America Egg Freezing and Embryo Banking Market Outlook, By Medical Fertility Preservation (2024-2032) ($MN)
  • Table 120 South America Egg Freezing and Embryo Banking Market Outlook, By Elective Fertility Preservation (2024-2032) ($MN)
  • Table 121 South America Egg Freezing and Embryo Banking Market Outlook, By End User (2024-2032) ($MN)
  • Table 122 South America Egg Freezing and Embryo Banking Market Outlook, By Fertility Clinics (2024-2032) ($MN)
  • Table 123 South America Egg Freezing and Embryo Banking Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 124 South America Egg Freezing and Embryo Banking Market Outlook, By Cryobanks (2024-2032) ($MN)
  • Table 125 South America Egg Freezing and Embryo Banking Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 126 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Country (2024-2032) ($MN)
  • Table 127 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Service Type (2024-2032) ($MN)
  • Table 128 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Egg Freezing (2024-2032) ($MN)
  • Table 129 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Embryo Banking (2024-2032) ($MN)
  • Table 130 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Other Service Types (2024-2032) ($MN)
  • Table 131 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Preservation Method (2024-2032) ($MN)
  • Table 132 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Slow Freezing (2024-2032) ($MN)
  • Table 133 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Vitrification (2024-2032) ($MN)
  • Table 134 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 135 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By <30 Years (2024-2032) ($MN)
  • Table 136 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By 30-39 Years (2024-2032) ($MN)
  • Table 137 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By >=40 Years (2024-2032) ($MN)
  • Table 138 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Other Age Groups (2024-2032) ($MN)
  • Table 139 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Technology (2024-2032) ($MN)
  • Table 140 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
  • Table 141 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
  • Table 142 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 143 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Application (2024-2032) ($MN)
  • Table 144 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Medical Fertility Preservation (2024-2032) ($MN)
  • Table 145 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Elective Fertility Preservation (2024-2032) ($MN)
  • Table 146 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By End User (2024-2032) ($MN)
  • Table 147 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Fertility Clinics (2024-2032) ($MN)
  • Table 148 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 149 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Cryobanks (2024-2032) ($MN)
  • Table 150 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Other End Users (2024-2032) ($MN)